#Japan #Tokyo #Sumitomo Bakelite #S-Bio #Organoid Research

Introduction to the S-BIO Webinar

Sumitomo Bakelite Co., Ltd. is delighted to announce the upcoming second installment of their S-BIO webinar series, focusing on the latest advancements in organoid production and drug development. Set to take place on September 10th, 2026, at 16:00 JST, this live Zoom webinar will welcome esteemed speakers from both Japan and abroad, who are leading voices in the fields of organoid research and drug discovery.

During the first half of the webinar, Dr. Hideya Sakaguchi, a prominent figure from the National Center for Child Health and Development, will deliver a talk discussing the foundations of neuro-organoid creation rooted in developmental biology, and the promising applications for drug development. Following this, the webinar will feature Thomas Mitchell and Ernst Wolvetang from The Organoid Company, who will introduce their groundbreaking automated technologies for the mass production of organoids aimed at toxicity testing.

Finally, the session will wrap up with a presentation from Sumitomo Bakelite, detailing the product range that supports organoid research.

Recommended Audience

This webinar is ideal for:

• - Researchers engaged in drug discovery using organoids and building disease models.
• - Those interested in the latest findings on neuro-organoids, including cortex, hippocampus, and spinal research.
• - Professionals looking into automating organoid cultivation and mastering high-throughput screening techniques.
• - Individuals working on drug metabolism studies or in vitro toxicity assessments.

Webinar Overview

Date and Time: September 10, 2026, from 16:00 to 17:30 (Japan Time)
Format: Live via Zoom Webinar
Language: English
Cost: Free (Registration required)
Organizer: Sumitomo Bakelite Co., Ltd.

Registration Information

To participate, please register through the provided URL or scan the QR code below:

• - Register from PC: [Link]
• - Register from Smartphone: [QR Code]

Speaker Introductions

Dr. Hideya Sakaguchi

Position: Director, Experimental Pharmacology Research Laboratory, National Center for Child Health and Development
Dr. Sakaguchi is a distinguished researcher who graduated from Kumamoto University in 2008. After working as a clinical doctor, he transitioned to basic research at RIKEN. He earned his PhD from Kyoto University Graduate School of Medicine in 2016 and has been instrumental in creating successful neuro-organoid models. He holds numerous accolades, including awards from the Japanese Society for Regenerative Medicine.

Thomas Mitchell

Position: CEO & Co-founder, The Organoid Company
Mr. Mitchell is a seasoned executive in the biotech field, specializing in drug development. He played a pivotal role at Finch Therapeutics and co-led collaborations with Takeda Pharmaceuticals. Currently, as CEO of The Organoid Company, he strives to resolve bottlenecks in automated organoid production.

Ernst Wolvetang

Position: CSO & Co-founder, The Organoid Company
Mr. Wolvetang is a leading expert in stem cell biology and organoid development. After obtaining his PhD from the University of Amsterdam, he became a pioneer in human embryonic stem cell research in Australia. He also leads the Queensland University Stem Cell Engineering Laboratory and oversees the Australian Organoid Facility.

Presentations Overview

• - Presentation 1: "Developmental Biology Based Neuro-Organoid Research Foundations and Expectations for Drug Discovery" by Dr. Hideya Sakaguchi
• - Presentation 2: "Self-healing Automated Manufacturing of Multi-lineage Organoids for Multi-organ Toxicity Testing" by Thomas Mitchell and Ernst Wolvetang

Contact for Inquiries

For questions, please reach out to:
Sumitomo Bakelite Co., Ltd. S-BIO Division, Marketing & Sales Department
Phone: 【East Japan】03(5462)4831 【West Japan】06(7669)0031
Inquiries: [Contact Link]